Pathologic Diagnosis and Genetic Analysis of Sequential Biopsy Following Coaxial Low-Power Microwave Thermal Coagulation For Pulmonary Ground-Glass Opacity Nodules

Overview

Journal Cardiovasc Intervent Radiol

Specialty Cardiology & Vascular Diseases

Date 2021 Apr 7

PMID 33825064

Citations 5

Authors

Jiachang Chi

Min Ding

Zhi Wang

Hao Hu

Yaoping Shi

Dan Cui

Xiaojing Zhao

Bo Zhai

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the feasibility, safety, and diagnostic performance of sequential core-needle biopsy (CNB) technique following coaxial low-power microwave thermal coagulation (MTC) for ground-glass opacity (GGO) nodules.

Materials And Methods: From December 2017 to July 2019, a total of 32 GGOs (with diameter of 12 ± 4 mm) in 31 patients received two times of CNBs, both prior to and immediately after MTC at a power of 20 watts. The frequency and type of complications associated with CNBs were examined. The pathologic diagnosis and genetic analysis were performed for specimens obtained from the two types of biopsy.

Results: The technical success rates of pre- and post-MTC CNBs were 94% and 100%, respectively. The complication rate was significantly lower with post-MTC CNB as compared to pre-MTC CNB (42% versus 97%, p < 0.001). Larger amount of specimens could be obtained by post-MTC CNB. The pathological diagnosis rate of post-MTC CNB was significantly higher than that of pre-MTC CNB (100% versus 75%, p = 0.008), whereas the success rates of genetic analysis were comparable between the two groups (100% versus 84%, p = 0.063). Regular ablation could be further performed after post-MTC CNB to achieve local tumor control.

Conclusion: Sequential biopsy following coaxial low-power MTC can reduce the risk of complications and provide high-quality specimens for pulmonary GGOs. Combining this technique with standard ablation allows for simultaneous diagnosis and treatment within a single procedure.

Citing Articles

Complications of synchronous microwave ablation and biopsy versus microwave ablation alone for pulmonary sub-solid nodules: a retrospective, large sample, case-control study.

Cao P, Wei Z, Xue G, Wang N, Li Z, Hu Y Quant Imaging Med Surg. 2024; 14(10):7218-7228.

PMID: 39429568 PMC: 11485351. DOI: 10.21037/qims-24-906.

Simultaneous percutaneous microwave ablation and biopsy for highly suspected malignant pulmonary nodules: a retrospective cohort study.

Zhang J, Xu K, Du K, Han X, Jiao D Quant Imaging Med Surg. 2023; 13(10):7214-7224.

PMID: 37869271 PMC: 10585563. DOI: 10.21037/qims-23-138.

Percutaneous core-needle biopsy before and immediately after coaxial microwave ablation in solid non-small cell lung cancer: the comparison of genomic testing from specimens.

Xu S, He L, Qi J, Kong F, Bie Z, Li Y Cancer Imaging. 2023; 23(1):93.

PMID: 37789413 PMC: 10548670. DOI: 10.1186/s40644-023-00610-6.

Microwave ablation with a blunt-tip antenna for pulmonary ground-glass nodules: a retrospective, multicenter, case-control study.

Wei Z, Chi J, Cao P, Jin Y, Li X, Ye X Radiol Med. 2023; 128(9):1061-1069.

PMID: 37458905 PMC: 10474204. DOI: 10.1007/s11547-023-01672-z.

Cost and effectiveness of microwave ablation versus video-assisted thoracoscopic surgical resection for ground-glass nodule lung adenocarcinoma.

Han X, Wei Z, Zhao Z, Yang X, Ye X Front Oncol. 2022; 12:962630.

PMID: 36276106 PMC: 9581221. DOI: 10.3389/fonc.2022.962630.

References

Hansell D, Bankier A, MacMahon H, McLoud T, Muller N, Remy J . Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008; 246(3):697-722. DOI: 10.1148/radiol.2462070712. View

Van Haren R, Correa A, Sepesi B, Rice D, Hofstetter W, Mehran R . Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing. Ann Thorac Surg. 2019; 107(3):936-940. DOI: 10.1016/j.athoracsur.2018.09.016. View

Park J, Lee K, Kim J, Shim Y, Kim J, Choi Y . Malignant pure pulmonary ground-glass opacity nodules: prognostic implications. Korean J Radiol. 2009; 10(1):12-20. PMC: 2647178. DOI: 10.3348/kjr.2009.10.1.12. View

Kim H, Shim Y, Lee K, Han J, Yi C, Kim Y . Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007; 245(1):267-75. DOI: 10.1148/radiol.2451061682. View

Iguchi T, Hiraki T, Gobara H, Fujiwara H, Matsui Y, Soh J . Percutaneous radiofrequency ablation of lung cancer presenting as ground-glass opacity. Cardiovasc Intervent Radiol. 2014; 38(2):409-15. DOI: 10.1007/s00270-014-0926-x. View

Hsu T, Fidler M, Gill I . Radiofrequency ablation of the kidney: acute and chronic histology in porcine model. Urology. 2000; 56(5):872-5. DOI: 10.1016/s0090-4295(00)00737-8. View

Clasen S, Krober S, Kosan B, Aebert H, Fend F, Bomches A . Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer. 2008; 113(11):3121-9. DOI: 10.1002/cncr.23882. View

Schneider T, Reuss D, Warth A, Schnabel P, von Deimling A, Herth F . The efficacy of bipolar and multipolar radiofrequency ablation of lung neoplasms - results of an ablate and resect study. Eur J Cardiothorac Surg. 2010; 39(6):968-73. DOI: 10.1016/j.ejcts.2010.08.055. View

Nguyen C, Scott W, Young N, Rader T, Giles L, Goldberg M . Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest. 2005; 128(5):3507-11. DOI: 10.1378/chest.128.5.3507. View

10.

Wang Q, Huang J, Ma K, Li T, Chen M, Wang S . Evaluation of ghost cell survival in the area of radiofrequency ablation. PLoS One. 2013; 7(12):e53158. PMC: 3534026. DOI: 10.1371/journal.pone.0053158. View

11.

Hasegawa T, Kondo C, Sato Y, Inaba Y, Yamaura H, Kato M . Pathologic Diagnosis and Genetic Analysis of a Lung Tumor Needle Biopsy Specimen Obtained Immediately After Radiofrequency Ablation. Cardiovasc Intervent Radiol. 2017; 41(4):594-602. DOI: 10.1007/s00270-017-1845-4. View

12.

Tselikas L, De Baere T, Deschamps F, Hakime A, Besse B, Teriitehau C . Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation. Eur Radiol. 2016; 27(3):1211-1217. DOI: 10.1007/s00330-016-4447-7. View

13.

Hasegawa T, Kondo C, Sato Y, Inaba Y, Yamaura H, Kato M . Diagnostic Ability of Percutaneous Needle Biopsy Immediately After Radiofrequency Ablation for Malignant Lung Tumors: An Initial Experience. Cardiovasc Intervent Radiol. 2016; 39(8):1187-92. DOI: 10.1007/s00270-016-1324-3. View

14.

Guo Z, Shi H, Li W, Lin D, Wang C, Liu C . Chinese multidisciplinary expert consensus: Guidelines on percutaneous transthoracic needle biopsy. Thorac Cancer. 2018; 9(11):1530-1543. PMC: 6209790. DOI: 10.1111/1759-7714.12849. View

15.

Yeow K, Su I, Pan K, Tsay P, Lui K, Cheung Y . Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest. 2004; 126(3):748-54. DOI: 10.1378/chest.126.3.748. View

16.

Tai R, Dunne R, Trotman-Dickenson B, Jacobson F, Madan R, Kumamaru K . Frequency and Severity of Pulmonary Hemorrhage in Patients Undergoing Percutaneous CT-guided Transthoracic Lung Biopsy: Single-Institution Experience of 1175 Cases. Radiology. 2015; 279(1):287-96. DOI: 10.1148/radiol.2015150381. View

17.

Lu C, Hsiao C, Chang Y, Lee J, Shih J, Wu L . Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation. J Thorac Oncol. 2011; 7(1):143-50. DOI: 10.1097/JTO.0b013e318233d7dd. View

18.

Inoue D, Gobara H, Hiraki T, Mimura H, Kato K, Shibamoto K . CT fluoroscopy-guided cutting needle biopsy of focal pure ground-glass opacity lung lesions: diagnostic yield in 83 lesions. Eur J Radiol. 2011; 81(2):354-9. DOI: 10.1016/j.ejrad.2010.11.025. View

19.

Tomiyama N, Yasuhara Y, Nakajima Y, Adachi S, Arai Y, Kusumoto M . CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. Eur J Radiol. 2006; 59(1):60-4. DOI: 10.1016/j.ejrad.2006.02.001. View